Torthaí cuardaigh - Carl D. Regillo

Beachtaigh na torthaí
  1. 1
    Baseline Predictors of 12-Month Treatment Response to Ranibizumab in Patients With Wet Age-Related Macular Degeneration

    Baseline Predictors of 12-Month Treatment Response to Ranibizumab in Patients With Wet Age-Related Macular Degeneration de réir Carl D. Regillo, Brandon Busbee, Allen C. Ho, Beiying Ding, Zdenka Hašková

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Long-term (60-month) results for the implantable miniature telescope: efficacy and safety outcomes stratified by age in patients with end-stage age-related macular degeneration

    Long-term (60-month) results for the implantable miniature telescope: efficacy and safety outcomes stratified by age in patients with end-stage age-related macular degeneration de réir David S. Boyer, K. Bailey Freund, Carl D. Regillo, Marc H. Levy, Sumit Garg

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Predictors of Diabetic Macular Edema Treatment Frequency with Ranibizumab During the Open-Label Extension of the RIDE and RISE Trials

    Predictors of Diabetic Macular Edema Treatment Frequency with Ranibizumab During the Open-Label Extension of the RIDE and RISE Trials de réir Charles C. Wykoff, Michael J. Elman, Carl D. Regillo, Beiying Ding, Na Lu, Ivaylo Stoilov

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Economic Evaluation of a Home-Based Age-Related Macular Degeneration Monitoring System

    Economic Evaluation of a Home-Based Age-Related Macular Degeneration Monitoring System de réir John S. Wittenborn, Traci E. Clemons, Carl D. Regillo, Nadim Rayess, Danielle Kruger, David B. Rein

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Twenty-four-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-Related Macular Degeneration

    Twenty-four-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-Related Macular Degeneration de réir Allen C. Ho, Brandon Busbee, Carl D. Regillo, Mark R. Wieland, Sherri A. Van Everen, Zhengrong Li, Roman G. Rubio, Phillip Lai

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Clinical Presentation of Rhegmatogenous Retinal Detachment during the COVID-19 Pandemic

    Clinical Presentation of Rhegmatogenous Retinal Detachment during the COVID-19 Pandemic de réir Luv Patel, Travis Peck, Matthew R. Starr, Michael J. Ammar, Khan Ma, Yoshihiro Yonekawa, Michael A. Klufas, Carl D. Regillo, Allen C. Ho, David Xu

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    ASSOCIATION BETWEEN HIGH-RISK DISEASE LOCI AND RESPONSE TO ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT FOR WET AGE-RELATED MACULAR DEGENERATION

    ASSOCIATION BETWEEN HIGH-RISK DISEASE LOCI AND RESPONSE TO ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT FOR WET AGE-RELATED MACULAR DEGENERATION de réir Anton Orlin, Dexter Hadley, Woohyok Chang, Allen C. Ho, Gary C. Brown, Richard Kaiser, Carl D. Regillo, Ashlee N. Godshalk, Audun Lier, Brian Kaderli, Dwight Stambolian

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Outcomes of Eyes Lost to Follow-up with Proliferative Diabetic Retinopathy That Received Panretinal Photocoagulation versus Intravitreal Anti–Vascular Endothelial Growth Factor

    Outcomes of Eyes Lost to Follow-up with Proliferative Diabetic Retinopathy That Received Panretinal Photocoagulation versus Intravitreal Anti–Vascular Endothelial Growth Factor de réir Anthony Obeid, Daniel Su, Samir Patel, Joshua H. Uhr, Durga S. Borkar, Xinxiao Gao, Mitchell S. Fineman, Carl D. Regillo, Joseph I. Maguire, Sunir J. Garg, Jason Hsu

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    Safety and efficacy of ixoberogene soroparvovec in neovascular age-related macular degeneration in the United States (OPTIC): a prospective, two-year, multicentre phase 1 study

    Safety and efficacy of ixoberogene soroparvovec in neovascular age-related macular degeneration in the United States (OPTIC): a prospective, two-year, multicentre phase 1 study de réir Arshad M. Khanani, David S. Boyer, Charles C. Wykoff, Carl D. Regillo, Brandon Busbee, Dante J. Pieramici, Carl J. Danzig, Brian C. Joondeph, James C. Major, Adam Turpcu, Szilárd Kiss

    Foilsithe / Cruthaithe 2023
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Juxtapapillary capillary hemangiomas

    Juxtapapillary capillary hemangiomas de réir Cathleen M. McCabe, Harry W. Flynn, Carol L Shields, Jerry A. Shields, Carl D Regillo, H. Richard McDonald, María H. Berrocal, J. Donald M. Gass, William F. Mieler

    Foilsithe / Cruthaithe 2000
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    Sustained Visual Acuity Loss in the Comparison of Age-Related Macular Degeneration Treatments Trials

    Sustained Visual Acuity Loss in the Comparison of Age-Related Macular Degeneration Treatments Trials de réir Gui‐shuang Ying, Benjamin J. Kim, Maureen G. Maguire, Jiayan Huang, Ebenezer Daniel, Glenn J. Jaffe, Juan E. Grunwald, Kevin J. Blinder, Christina J. Flaxel, Firas M. Rahhal, Carl D. Regillo, Daniel Martín

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    TREAT-AND-EXTEND REGIMENS WITH ANTI-VEGF AGENTS IN RETINAL DISEASES

    TREAT-AND-EXTEND REGIMENS WITH ANTI-VEGF AGENTS IN RETINAL DISEASES de réir K. Bailey Freund, Jean‐François Korobelnik, Robert G. Devenyi, Carsten Framme, John Galic, Edward N. Herbert, Hans Hoerauf, Paolo Lanzetta, Stephan Michels, Paul Mitchell, Jordi Monés, Carl D. Regillo, Ramin Tadayoni, James Talks, Sebastián Wolf

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    KESTREL and KITE Phase 3 Studies: 100-Week Results With Brolucizumab in Patients With Diabetic Macular Edema

    KESTREL and KITE Phase 3 Studies: 100-Week Results With Brolucizumab in Patients With Diabetic Macular Edema de réir Charles C. Wykoff, Justus G. Garweg, Carl D. Regillo, Eric H. Souied, Sebastián Wolf, Dilsher S. Dhoot, Hansjuergen Agostini, Andrew Chang, Augustinus Laude, J Wachtlin, Lidija Kovacic, Lixin Wang, Ying Wang, Emmanuel Bouillaud, David M. Brown

    Foilsithe / Cruthaithe 2023
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration

    The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration de réir Peter A. Campochiaro, Dennis M. Marcus, Carl C. Awh, Carl D. Regillo, Anthony P. Adamis, Vladimir Bantseev, Ya‐Wen Chiang, Jason S. Ehrlich, Signe Erickson, William D. Hanley, Joshua Horvath, Katie F. Maass, Natasha Singh, Fan Tang, Giulio Barteselli

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    Bacterial Dispersion Associated With Various Patient Face Mask Designs During Simulated Intravitreal Injections

    Bacterial Dispersion Associated With Various Patient Face Mask Designs During Simulated Intravitreal Injections de réir Samir Patel, Raziyeh Mahmoudzadeh, Mirataollah Salabati, Rebecca R. Soares, John W. Hinkle, Jason Hsu, Sunir J. Garg, Carl D. Regillo, Allen C. Ho, Michael N. Cohen, Khan Ma, Yoshihiro Yonekawa, Allen Chiang, Omesh P. Gupta, Ajay E. Kuriyan

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    Targeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration

    Targeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration de réir Brian L. Yaspan, David F. Williams, Frank G. Holz, Carl D. Regillo, Zhengrong Li, Amy Dressen, Menno van Lookeren Campagne, Kha Le, Robert Graham, Tatiana Beres, Tushar Bhangale, Lee Honigberg, Ashley Smith, Erin C. Henry, Carole Ho, Erich C. Strauss

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    Primary Retinal Detachment Outcomes Study Report Number 2

    Primary Retinal Detachment Outcomes Study Report Number 2 de réir Edwin H. Ryan, Claire Ryan, Nora J. Forbes, Yoshihiro Yonekawa, Sushant Wagley, Robert A. Mittra, D. Wilkin Parke, Daniel P. Joseph, Geoffrey G. Emerson, Gaurav K. Shah, Kevin J. Blinder, Antonio Capone, George A. Williams, Dean Eliott, Omesh P. Gupta, Jason Hsu, Carl D. Regillo

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    Artificial Intelligence Detection of Diabetic Retinopathy

    Artificial Intelligence Detection of Diabetic Retinopathy de réir Jennifer I. Lim, Carl D. Regillo, Srinivas R. Sadda, Eli Ipp, Malavika Bhaskaranand, Chaithanya Ramachandra, Kaushal Solanki, Harvey Dubiner, Grace A. Levy-Clarke, Richard D. Pesavento, Mark D. Sherman, Steven Silverstein, Brian Kim, Gerald B. Walman, Barbara A. Blodi, Amitha Domalpally, Susan Reed, James Reimers, Kris Lang, Holy Cohn, Ruth Shaw, Sheila Watson, Andrew Ewen, Nancy Barrett, Maria Swift, Jeffrey Gornbein

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    Five-Year Safety and Performance Results from the Argus II Retinal Prosthesis System Clinical Trial

    Five-Year Safety and Performance Results from the Argus II Retinal Prosthesis System Clinical Trial de réir Lyndon da Cruz, Jessy D. Dorn, Mark S. Humayun, Gislin Dagnelie, James T. Handa, Pierre‐Olivier Barale, José‐Alain Sahel, Paulo Stanga, Farhad Hafezi, Avinoam B. Safran, Joël Salzmann, Arturo Santos, David G. Birch, Rand Spencer, Artur V. Cideciyan, Eugene de Juan, Jacque L. Duncan, Dean Eliott, Amani A. Fawzi, Lisa C. Olmos de Koo, Allen C. Ho, Gary C. Brown, Julia A. Haller, Carl D. Regillo, Lucian V. Del Priore, Aries Arditi, Robert J. Greenberg

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  20. 20
    Long-Term Results from an Epiretinal Prosthesis to Restore Sight to the Blind

    Long-Term Results from an Epiretinal Prosthesis to Restore Sight to the Blind de réir Allen C. Ho, Mark S. Humayun, Jessy D. Dorn, Lyndon da Cruz, Gislin Dagnelie, James T. Handa, Pierre‐Olivier Barale, José‐Alain Sahel, Paulo Stanga, Farhad Hafezi, Avinoam B. Safran, Joël Salzmann, Arturo Santos, David G. Birch, Rand Spencer, Artur V. Cideciyan, Eugene de Juan, Jacque L. Duncan, Dean Eliott, Amani A. Fawzi, Lisa C. Olmos de Koo, Gary C. Brown, Julia A. Haller, Carl D. Regillo, Lucian V. Del Priore, Aries Arditi, Duane R. Geruschat, Robert J. Greenberg

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: